Skip to main content

Beckman Coulter Teams with US, Italian Researchers for CVD, Hypertension Signatures

NEW YORK (GenomeWeb News) - Beckman Coulter has started a research collaboration with Thomas Jefferson University of Philadelphia and the Laboraf Diagnostica e Ricerca San Raffaele in Milan, Italy, aimed at researching genetic signatures for cardiovascular disease and obesity-related hypertension.
Under the collaboration, the universities and the company will use the company's Biomek FXP Laboratory Automation Workstation and GenomeLab SNPStream Genotyping System to develop research protocols and assays. Beckman Coulter will have the right to exclusively license commercial applications that result from the collaboration.
Beckman intends to use the genetic signatures discovered in the alliance to develop content for its next-generation molecular diagnostics platform, which it plans to launch in 2010.
“The discovery of genetic factors for both CVD and obesity may lead to development of readily-accessible diagnostic tests that enable more rapid assessment, earlier treatment, and preventive measures,” Bruce Wallace, president of Beckman Coulter’s molecular diagnostics business center, said in a statement.

The Scan

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.